Yuri Fesko is an Oncology physician affiliated with Quest Diagnostics. OpenAlex indexes 13 publications with 486 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer’s disease pathology
The Journal of Prevention of Alzheimer s Disease
2026 - New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic
JCO Clinical Cancer Informatics
2022 - Molecular reflex testing in non-small cell lung cancer: An optimal approach?
Journal of Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Michael K. Racke
Quest Diagnostics
Michael McPhaul, MD
Quest Diagnostics
Ronald Luff, MD
Quest Diagnostics
Jay Wohlgemuth
Quest Diagnostics
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”